Table of Content



Chapter 1 Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Source Type
1.1.2. Product Service Type
1.1.3. Disease Indication Type
1.1.4. Regional Scope
1.1.5. Estimates And Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Gvr’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details Of Primary Research
1.4. Information Or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Region Wise Market Calculation
1.6.1. Region Wise Market: Base Estimates
1.6.2. Global Market: Cagr Calculation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.7.2.1. Service Segment Analysis
1.8. List Of Primary Sources
1.9. List Of Abbreviations
1.10. List Of Secondary Sources
1.11. Objectives
1.11.1. Objective - 1:
1.11.2. Objective - 2:
1.11.3. Objective - 3:
1.11.4. Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Biologics Contract Development Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing adoption of advanced technologies
3.2.3 Increasing mergers and collaborations
3.2.4 Favourable environment for clinical trials in developing countries
3.2.5 Increasing outsourcing of R&D activities
3.2.6 Market Restraint Analysis
3.2.7 Intellectual property rights issues
3.3 Penetration & Growth Prospect Mapping
3.4 Biologics Contract Development: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 PESTEL Analysis
Chapter 4 Biologics Contract Development Market: Source Type Segment Analysis
4.1 Biologics Contract Development Market: Market Share Analysis, 2019 & 2027
4.1.1 Microbial
4.1.1.1 Microbial market, 2016 - 2027 (USD Million)
4.1.2 Mammalian
4.1.2.1 Mammalian market, 2016 - 2027 (USD Million)
4.1.3 Others
4.1.3.1 Others market, 2016 - 2027 (USD Million)
Chapter 5 Biologics Contract Development Market: Product Service Segment Analysis
5.1 Biologics Contract Development Market: Market Share Analysis, 2019 & 2027
5.2 Cell Line Development
5.2.1 Cell Line Development Market, 2016 - 2027 (USD Million)
5.2.1.1 Microbial Cell Line Development
5.2.1.1.1 Microbial Cell Line Development Market, 2016 - 2027 (USD Million)
5.2.1.2 Mammalian Cell Line Development
5.2.1.2.1 Mammalian Cell Line Development Market, 2016 - 2027 (USD Million)
5.2.1.3 Others
5.2.1.3.1 Others Market, 2016 - 2027 (USD Million)
5.3 Process Development
5.3.1 Process Development Market, 2016 - 2027 (USD Million)
5.3.2 Upstream Process Development
5.3.2.1 Upstream Process Development Market, 2016 - 2027 (USD Million)
5.3.2.1.1 Microbial
5.3.2.1.2 Microbial Market, 2016 - 2027 (USD Million)
5.3.2.1.3 Mammalian
5.3.2.1.4 Mammalian Market, 2016 - 2027 (USD Million)
5.3.2.1.5 Others
5.3.2.1.6 Others Market, 2016 - 2027 (USD Million)
5.3.3 Downstream Process Development
5.3.3.1 Downstream Process Development, 2016 - 2027 (USD Million)
5.3.3.1.1 Impurity, Isolation, & Identification
5.3.3.1.3 Physicochemical Characterization
5.3.3.1.4 Physicochemical Characterization Market, 2016 - 2027 (USD Million)
5.3.3.1.5 Pharmaceutical Analysis
5.3.3.1.6 Pharmaceutical Analysis Market, 2016 - 2027 (USD Million)
5.3.3.1.7 Others
5.3.3.1.8 Others Market, 2016 - 2027 (USD Million)
5.4 Downstream Process, By Product
5.4.1 Mabs (Monoclonal Antibodies)
5.4.1.1 Mabs (Monoclonal Antibodies) Market, 2016 - 2027 (USD Million)
5.4.2 Recombinant Proteins
5.4.2.1 Recombinant Proteins Analysis Market, 2016 - 2027 (USD Million)
5.4.2.1.1 Others
5.4.2.1.2 Others Market, 2016 - 2027 (USD Million)
5.5 Other Product Service (Quality And Regulatory Services, Etc)
5.5.1 Others Market, 2016 - 2027 (USD Million)
Chapter 6 Biologics Contract Development Market: Disease Indication Segment Analysis
6.1 Biologics Contract Development Market: Market Share Analysis, 2019 & 2027
6.2 Oncology
6.2.1 Oncology Market, 2016 - 2027 (USD Million)
6.3 Immunological Disorders
6.3.1 Immunological Disorders Market, 2016 - 2027 (USD Million)
6.4 Cardiovascular Disorders
6.4.1 Cardiovascular Disorders Market, 2016 - 2027 (USD Million)
6.5 Haematological Disorders
6.5.1 Haematological Disorders Market, 2016 - 2027 (USD Million)
6.5.2 Others
6.5.2.1 Others Market, 2016 - 2027 (USD Million)
Chapter 7 Biologics Contract Development Market: Regional Analysis
7.1 Biologics Contract Development: Regional Market Share Analysis, 2019 & 2027
7.2 North America
7.2.1 North America Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.2.2 The U.S.
7.2.2.1 The U.S. Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Europe Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3.2 The U.K.
7.3.2.1 The U.K. Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3.4 France
7.3.4.1 France Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4.2 China
7.4.2.1 China Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4.3 India
7.4.3.1 India Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4.4 Japan
7.4.4.1 Japan Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.6 MEA
7.6.1 MEA Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Biologics Contract Development Market, 2016 - 2027 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Biologics Contract Development Market, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.2 Company Profile
8.2.1 Wuxi Biologics
8.2.1.1 Company Overview
8.2.1.2 Financial performance
8.2.1.3 Service Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Abzena Ltd.
8.2.2.1 Company Overview
8.2.2.2 Service benchmarking
8.2.2.3 Strategic Initiatives:
8.2.3 FUJIFILM Diosynth Biotechnologies
8.2.3.1 Company Overview
8.2.3.2 Financial performance
8.2.3.3 Service benchmarking
8.2.3.4 Strategic initiatives
8.2.4 KBI Biopharma
8.2.4.1 COMPANY overview
8.2.4.2 Service Benchmarking
8.2.4.3 Strategic Initiatives
8.2.5 AGC Biologics
8.2.5.1 Company Overview
8.2.5.2 Financial performance
8.2.5.3 Service Benchmarking
8.2.5.4 Strategic Initiatives:
8.2.6 SE Thermo Fischer (Patheon)
8.2.6.1 Company Overview
8.2.6.2 Financial performance
8.2.6.3 Service Benchmarking
8.2.6.4 Strategic Initiatives:
8.2.7 Lakepharma, Inc.
8.2.7.1 Company overview
8.2.7.2 Service Benchmarking
8.2.7.3 Strategic Initiatives:
8.2.8 Genscript
8.2.8.1 Company overview
8.2.8.2 Financial Performance
8.2.8.3 Service Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 BioNova Scientific
8.2.9.1 Company overview
8.2.9.2 Service Benchmarking
8.2.10 BI BioXcellence
8.2.10.1 Company Overview
8.2.10.2 Financial Performance
8.2.10.3 SERVICE BENCHMARKING
8.2.10.4 Strategic initiatives:
8.2.11 STC Biologics
8.2.11.1 Company Overview
8.2.11.2 Service Benchmarking



List of Tables



Table 1 Country share estimation
Table 2 List of Abbreviation
Table 3 List of secondary sources